Psoriasis Clinical Trial
New Psoriasis Treatment
|
|
Hemp Moisturizer Living Hemp is an emollient and beautifying cream. Hemp is high in Omega 3 and 6 fatty acids, which help to revitalize and replenish the skin. Clinical trials have shown that Omega 3 and Omega 6 fatty acids present in hemp oil can help dry skin defects and may be beneficial for conditions such as eczema and psoriasis. The Living Hemp Moisturizer is made with 100% organic ingredients: * Cacao but… |
|
|
Dermalight Photodermatology Product Bulb … |
|
|
Biologics in General Medicine $18.00 This is the first book to cover every angle in the clinical application of biologics. Readers will not only find that all of the biologics currently approved for clinical use are delineated in a standardized way, but also the “differential therapy” with biologics in fields including dermatology and neurology is described in detail and summarized in treatment algorithms. Shorter sections on biologi… |
|
|
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicenter, double-blind trial.(WASHINGTON WHISPERS): An article from: Journal of Drugs in Dermatology $5.95 This digital document is an article from Journal of Drugs in Dermatology, published by Thomson Gale on February 1, 2006. The length of the article is 906 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTi… |
|
|
Ustekinumab bests etanercept in phase III study.(PSORIASIS): An article from: Skin & Allergy News $9.95 This digital document is an article from Skin & Allergy News, published by International Medical News Group on April 1, 2009. The length of the article is 410 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Ustekinumab bests etaner… |
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
